Abstract
In this pilot study, we show that periprocedural administration of tirofiban during stenting of critically stenosed saphenous vein grafts, significantly reduces the occurrence of postprocedural minor myocardial necroses.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
MeSH terms
-
Aged
-
Angioplasty, Balloon, Coronary / instrumentation*
-
Coronary Angiography
-
Coronary Artery Bypass / adverse effects*
-
Coronary Artery Bypass / methods
-
Coronary Restenosis / blood
-
Coronary Restenosis / etiology
-
Coronary Restenosis / therapy*
-
Female
-
Fibrinolytic Agents / therapeutic use
-
Follow-Up Studies
-
Graft Occlusion, Vascular / blood
-
Graft Occlusion, Vascular / etiology
-
Graft Occlusion, Vascular / therapy*
-
Humans
-
Male
-
Pilot Projects
-
Saphenous Vein / transplantation
-
Stents*
-
Tirofiban
-
Treatment Outcome
-
Troponin T / blood*
-
Tyrosine / analogs & derivatives*
-
Tyrosine / therapeutic use
-
Ultrasonography, Doppler / methods
-
Ultrasonography, Interventional
Substances
-
Fibrinolytic Agents
-
Troponin T
-
Tyrosine
-
Tirofiban